Navigation Links
Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients

s that could delay, divert or change any of them, and could cause actual outcomes and results to differ materially from current expectations. No forward-looking statement can be guaranteed. There can be no guarantee that a registrational submission will be made to the FDA based on the data described in this press release or if such registrational submission is made, that it would receive FDA approval. Forward-looking statements in this press release should be evaluated together with the many uncertainties that affect Bristol- Myers Squibb's business, particularly those identified in the cautionary factors discussion in Bristol-Myers Squibb's Annual Report on Form 10-K for the year ended December 31, 2006 and in our Quarterly Reports on Form 10-Q. Bristol-Myers Squibb undertakes no obligation to publicly update any forward- looking statement, whether as a result of new information, future events or otherwise.

CONTACT: Media and Investor Contacts: Rebecca Gregory, CorporateCommunications of ImClone Systems Incorporated, +1-646-638-5058,; Media: Madeline Malia, +1-609-252-3347,, or Tony Plohoros, +1-609-252-7938,, both of Bristol-Myers Squibb; Bristol-Myers Squibb;or Investors: John Elicker of Bristol-Myers Squibb, +1-212-546-3775, media@imclone.com Madeline.Malia@bms.com tony.plohoros@bms.com John.Elicker@bms.com

Web site: http://www.ERBITUX.com/

Ticker Symbol: (NASDAQ-NMS:IMCL),(NYSE:BMY)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
2. YM BioSciences Reports AeroLEF Randomized Phase IIb Trial Meets Primary Endpoint in Patients with Post-Surgical Pain
3. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
4. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
5. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
(Date:5/5/2015)... Oregon , May 5, 2015 Big ... in the US, Europe , ( France ... , Spain , UK) and Japan ... etiology are reviewed. The report provides the 5-year test volume and ... HCV, HCV NAT, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe ...
(Date:5/5/2015)...  Image Stream Medical, a leader in OR video ... of the largest group purchasing organizations, serving four out ... of the three-year agreement, Image Stream,s portfolio of EasySuite™ ... available to MedAssets members beginning on July 1, 2015. ... CEO Eddie Mitchell said, ...
(Date:5/5/2015)... , May 05, 2015 Research and ... the addition of the "Clinical Laboratory,Molecular Diagnostics ... 2015 to 2019 - Asia Pacific Version" ... that just keeps on growing. Clinical laboratory testing ... in biotechnology, especially genomics. A range of dynamic ...
Breaking Medicine Technology:2015 Opportunities in the Global Hepatitis Diagnostic Testing Market: Big Market Research 22015 Opportunities in the Global Hepatitis Diagnostic Testing Market: Big Market Research 3Image Stream Medical Announces Agreement with MedAssets 2Asia Pacific Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market Report 2015-2019 2
... Inc. (NTI(R)) (Nasdaq: NTII ), today ... of approximately $1.5 million from Merz Pharmaceuticals GmbH ... of Alzheimer,s disease. Under an exclusive marketing agreement, ... sales of Memantine by Merz and its marketing ...
... leading provider of clinical services and trial management technologies ... selected along with its client Genentech, Inc as the ... it,s Clinical Trial Portal solution. Winners were selected ... reviewed panel of 14 expert judges. The ePharmaSolutions ...
Cached Medicine Technology:ePharmaSolutions' Clinical Trial Investigator Portal Wins Bio-IT World 2009 Best Practice Award 2
(Date:5/5/2015)... May 05, 2015 This year, PolyU ... four Special Merit Awards, three Gold Medals and four ... are described as follows: , (1) Grand Prize and ... Mannequin for Fashion Design and Fitting, Principal Investigator: Dr ... The apparel industry relies very much on the “mannequin” ...
(Date:5/5/2015)... VA (PRWEB) May 05, 2015 ... and mission-focused company serving the federal government, today ... Inc. (CCSi). CCSi provides solutions exclusively to ... with extensive experience in cyber security, health services, ... business processes and industry-relevant credentials as a Third ...
(Date:5/5/2015)... Pittsburgh, Pa (PRWEB) May 05, 2015 ... signs of accelerated aging that correlate with slower information ... of Pittsburgh Graduate School of Public Health . ... middle-aged patients with type 1 diabetes for cognitive difficulties. ... manage their diabetes. The study, funded by the ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 Rare ... Initiative, a new study aimed at determining how crowdfunding ... RG is an international non-profit providing rare disease patients ... technology, connections to scientists and researchers, and help for ... , “I am excited to see how crowdfunding will ...
(Date:5/5/2015)... 2015 Barnabas Health, the state’s largest ... a new healthy cooking video series starring celebrity chef ... Bravo’s Top Chef, teamed up with Barnabas Health to ... living. In support of the series, Barnabas Health ... videos will be showcased on social media. ...
Breaking Medicine News(10 mins):Health News:PolyU wins top prizes in Geneva’s Invention Expo 2Health News:PolyU wins top prizes in Geneva’s Invention Expo 3Health News:PolyU wins top prizes in Geneva’s Invention Expo 4Health News:PolyU wins top prizes in Geneva’s Invention Expo 5Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 2Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 3Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 4Health News:Accelerated Brain Aging in Type 1 Diabetes Related to Cognitive Complications 2Health News:Accelerated Brain Aging in Type 1 Diabetes Related to Cognitive Complications 3Health News:Accelerated Brain Aging in Type 1 Diabetes Related to Cognitive Complications 4Health News:Rare Genomics Institute to Study Impact of Crowdfunding on Rare Diseases 2Health News:Barnabas Health Teams Up With Celebrity Chef Sam Talbot To Launch "Life Is Better Healthy" Cooking Video Series 2Health News:Barnabas Health Teams Up With Celebrity Chef Sam Talbot To Launch "Life Is Better Healthy" Cooking Video Series 3
... a,statement by Mark J. Feldman, DMD, President, American ... of the U.S. population now receives,optimally fluoridated water:, ... the Centers for Disease,Control and Prevention about the ... water. We know from years of experience and,scientific ...
... Patient Assistance Program from the Patient Advocate,Foundation and ... and Pay Medical Bills When Diagnosed with a ... July 10 The Patient,Advocate Foundation (PAF) - ... to tens of thousands of patients every year,who ...
... to Surpass Competition in Most Categories of Customer ... Satisfaction, According to ... Inc. (Nasdaq:,ICAD), an industry-leading provider of Computer-Aided Detection (CAD),solutions ... the,Company has achieved record-high customer satisfaction ratings in the,Mammography ...
... Females scored worse than males on neurocognitive tests; reason ... Being female and having a history of concussions both ... to a new study done on soccer players. , ... the American Orthopaedic Society for Sports Medicine annual meeting ...
... available in German . , Brush your ... regular tooth care is the only way to banish the ... The tooth surface wears down and gets uneven ?and the ... rough surface. Dentists therefore offer professional cleaning services, removing plaque ...
... American to Stand Behind Our ... ... focused on creating awareness for the most underserved and,at-risk groups in our ... project,s goal is to assist those soldiers,who have been wounded in conflict ...
Cached Medicine News:Health News:1,000th Uninsured Virginia Patient Secures Access to Quality Medical Care Through Virginia Cares Uninsured Program (VCUP) 2Health News:1,000th Uninsured Virginia Patient Secures Access to Quality Medical Care Through Virginia Cares Uninsured Program (VCUP) 3Health News:iCAD Achieves Record-High Ratings in Mammography CAD User Satisfaction 2Health News:iCAD Achieves Record-High Ratings in Mammography CAD User Satisfaction 3Health News:Gender Plays Role in Post-Concussion Healing 2Health News:Polished to perfection 2Health News:Purple Dog Tag Launches; Provides Hope and Healing to Thousands of US Servicemen & Veterans 2
A fluorogenic enzyme-linked immunoassay (ELISA) for the quantitative measurement of myoglobin in human serum or plasma aiding in the diagnosis of acute myocardial infarction (AMI). Features : Dry che...
The Acute Care myoglobin method is an in vitro diagnostic test for the measurement of myoglobin in heparinized whole blood /plasma. Myoglobin measurements can be used as an aid in diagnosing myocardi...
... The VITROS ECi brings true automation ... immunodiagnostic testing. Highly sensitive assays for ... and bone metabolism testing are currently ... development. The VITROS ECi can simultaneously ...
IRMA kit for detection of the cardiac marker Myoglobin...
Medicine Products: